MARKETS SPECTATOR: Continue with CSL, take Ten

Brokers are expecting more good times ahead for this year's standout stock, bio pharmaceutical company CSL, while Credit Suisse has a surprising take on Ten.


SMS Code Sent…

Hi {{ user.FirstName }}

Looks like you've already taken a free trial

We have sent you a code via SMS to {{user.DayPhone}}

please enter this code below to activate your membership

If you didn't receive SMS code please

Looks you are already a member. Please enter your password to proceed

Verify your mobile number to unlock a FREE trial

Please sign up for full access

Updating information

Please wait ...

Related Articles